Digital Health Global

JANUARY 8, 2024

A Tufts Center for the Study of Drug Development study shows that, on average, decentralized trials can achieve net financial benefits from five to 13 times for Phase II and Phase III trials, equating to roughly $10 million ROI and $39 million ROI respectively. Medable, which ranked in the top 8% of software companies on the 2023 Inc.

Life Science 88

Life Science Drug Development Pharmaceuticals HIPAA 88

Healthcare IT Today

NOVEMBER 14, 2022

Latest Round of Investment in the Family Engagement Technology Company Led by Bradford Whitmore and Mountain Group Partners, with Participation by SeedtoB Capital and the Rash Family Office. The Series B financing was led by Brad Whitmore and Mountain Group Partners (MGP), with participation from SeedtoB Capital and the Rash Family Office.

Life Science 95

Life Science HIPAA Drug Development healthcare technology 95

Healthcare IT News - Telehealth

MAY 6, 2020

Biofourmis’ digital therapeutics are used for RPM across three primary healthcare stakeholder groups: health systems, payers and pharmaceutical companies. Vitals are transmitted via a secure cellular 4G network to Spry Health’s cloud-based analytics engine, which meets HIPAA requirements for data security.

Connected Health 188

Connected Health Telehealth Pharmaceuticals EHR 188